The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Novartis
Clinical validation of a prognostic 11-gene assay in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma (CM).
 
Claus Garbe
Honoraria - Amgen; Bristol-Myers Squibb; MSD; NeraCare GmbH; Novartis; Philogen; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; NeraCare GmbH; Novartis; Philogen; Pierre Fabre; Roche; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); NeraCare GmbH (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; NeraCare GmbH; Novartis; Philogen; Roche; Sanofi
 
Tobias Sinnberg
Research Funding - Novartis (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Novartis
 
Heike Niessner
Research Funding - Novartis (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Novartis
 
Heiko Sülberg
Consulting or Advisory Role - NeraCare GmbH
 
Thomas K. Eigentler
Consulting or Advisory Role - Bristol-Myers Squibb; Roche Pharma AG
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Roche Pharma AG
 
Teresa Amaral
No Relationships to Disclose